Results 251 to 260 of about 294,536 (285)

Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections. [PDF]

Nat Commun
Zambrana JV, Mellis IA, Shotwell A, Maier HE, Saborio Y, Barillas C, Lopez R, Vasquez G, Plazaola M, Sanchez N, Ojeda S, Gilbertson I, Kuan G, Wang Q, Liu L, Balmaseda A, Ho DD, Gordon A.   +17 more
europepmc   +1 more source

Pre-existing cross-reactive immunity to highly pathogenic avian influenza 2.3.4.4b A(H5N1) virus in the United States. [PDF]

Nat Commun
Li ZN, Liu F, Jung YJ, Jefferson S, Holiday C, Gross FL, Tzeng WP, Carney P, Kates A, York IA, Safdar N, Zhou J, Medina MJ, Cioce V, Oshansky CM, Todd Davis C, Stevens J, Tumpey T, Levine MZ.   +18 more
europepmc   +1 more source

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection. [PDF]

Open Forum Infect Dis
Pernikoff S, Clurman A, Rötepohl M, Galanter N, Bibby M, Harris E, Stevens-Ayers T, Xie H, Ueda Oshima M, Cheng GS, Englund JA, Boeckh MJ, Boonyaratanakornkit J.   +12 more
europepmc   +1 more source

MERS-CoV RBD-mRNA Presents Better Immunogenicity and Protection than the Spike-mRNA. [PDF]

Cells
Liu Q, Verma AK, Guan X, Qian S, Perlman S, Du L.   +5 more
europepmc   +1 more source

Seroprevalence survey and estimated infection fatality rate of SARS-CoV-2 in Daegu, Republic of Korea - Lessons learned for preparing for new emerging viral disease epidemics: A cross-sectional study. [PDF]

Medicine (Baltimore)
Kim KH, Kim CK, Ko MK, Yi J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Broadly Neutralizing Antiviral Antibodies

Annual Review of Immunology, 2013
A fascinating aspect of viral evolution relates to the ability of viruses to escape the adaptive immune response. The widely held view has been that the great variability of viral glycoproteins would be an absolute obstacle to the development of antibody-based therapies or vaccines that could confer broad and long-lasting protection.
Corti D., Lanzavecchia A.
openaire   +2 more sources

Neutralizing Antibodies Against Calcitonin

Hormone and Metabolic Research, 1993
The use of calcitonin (CT) is established as a treatment of Paget's disease of bone and postmenopausal osteoporosis (PMO). Salmon calcitonin (sCT), which differs in 14 of the 32 amino acids from human calcitonin, has found a wider distribution world wide, although antibody formation against sCT has been reported in more than 70% of the patients on ...
A, Grauer, H H, Reinel, R, Ziegler, F, Raue   +3 more
openaire   +2 more sources

Production of Neutralizing Antibody

2018
Techniques employing monoclonal antibodies (mAbs) are widely used in the initial development phase of biologics. The usefulness of mAbs in basic RA research has been established based on their characteristics, including specificity of binding, homogeneity, and ability to be produced on a large scale.
Erika, Takemasa, Shuang, Liu, Hitoshi, Hasegawa   +2 more
openaire   +2 more sources